EUVIMEDEUVIMED entdecken
Crossref

Mendelian randomization analysis of lipids traits and lipid-lowering drug-targets in relation to cognitive status

Jiajing Fu, Zhaoli Zhang, Yi Xu, Liuhu Han, Huimin Fan, Yao Lu

Journal of Affective Disorders · 2025

DOI: 10.1016/j.jad.2025.120057 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Affective Disorders, 2025. Verfasst von Jiajing Fu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, China. Hauptthemen laut MEDLINE: Hypolipidemic Agents, Cognitive Dysfunction, Dyslipidemias, Lipids. Die Arbeit nennt 57 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Cognitive impairment is increasingly prevalent among older adults, posing a major public health challenge. While lipid-lowering medications are widely used to manage dyslipidemia in this population, the causal relationship between lipid levels and cognitive function remains unclear. This study investigates genetically- predicted lipid traits, lipid-lowering drug-targets, and their associations with cognitive status. METHODS: Genetic variants associated with lipid features or lipid-lowering drug-targets were identified using data from the GLGC. Cognitive summary statistics were obtained from six independent GWAS datasets. Significant drug-targets were further assessed using SMR and co-localization to account for potential confounding effects. RESULTS: No significant associations were found between lipid traits or eight of the nine lipid-reducing drug-targets and cognitive outcomes. However, genetic inhibition of NPC1L1 was associated with a higher risk of cognitive impairment across three distinct datasets (β1 = -0.191 [95 % CI: -0.307 to -0.075], p = 0.023; β2 = -0.288 [95 % CI: -0.394 to -0.182], p = 5.616 × 10-6; β3 = -0.488 [95 % CI: -0.760 to -0.217], p = 0.011). SMR analysis revealed significant associations between NPC1L1 expression in subcutaneous adipose tissue and cognitive outcomes (β1 = 0.020 [95 % CI: 0.003 to 0.037], p = 0.019; β2 = 0.026 [95 % CI: 0.009 to 0.043], p = 0.003; β3 = 0.054 [95 % CI: 0.009 to 0.099], p = 0.019). CONCLUSION: These findings do not support dyslipidemia as a causal factor for cognitive impairment. However, NPC1L1 inhibition, as targeted by ezetimibe, may increase the risk of cognitive decline, independent of its lipid-lowering effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypolipidemic AgentsCognitive DysfunctionDyslipidemiasLipidsCognitionHumansMendelian Randomization AnalysisGenome-Wide Association StudyMaleMembrane ProteinsMembrane Transport ProteinsAgedPolymorphism, Single NucleotideFemale

Stichwörter der Autor:innen

Cognitive statusDrug-targetLipidsMendelian randomization

Substanzen

Hypolipidemic AgentsNPC1L1 protein, humanLipidsMembrane ProteinsMembrane Transport Proteins

Autor:innen und Institutionen

  • Department of Anesthesiology, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, China.
  • State Key Laboratory of Experimental Hematology, Boren Clinical Translational Center, Department of Hematology, Beijing Gobroad Hospital, Beijing, China.
  • Department of Anesthesiology, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, China; Ambulatory Surgery Center, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, China. El…

Zitieren

APA

Fu, J., Zhang, Z., Xu, Y., Han, L., Fan, H., & Lu, Y. (2025). Mendelian randomization analysis of lipids traits and lipid-lowering drug-targets in relation to cognitive status. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2025.120057

Vancouver

Fu J, Zhang Z, Xu Y, Han L, Fan H, Lu Y. Mendelian randomization analysis of lipids traits and lipid-lowering drug-targets in relation to cognitive status. Journal of Affective Disorders. 2025. doi:10.1016/j.jad.2025.120057

BibTeX
@article{Fu2025,
  author = {Fu, Jiajing and Zhang, Zhaoli and Xu, Yi and Han, Liuhu and Fan, Huimin and Lu, Yao},
  title = {Mendelian randomization analysis of lipids traits and lipid-lowering drug-targets in relation to cognitive status},
  journal = {Journal of Affective Disorders},
  year = {2025},
  doi = {10.1016/j.jad.2025.120057}
}
Kostenlos starten →